The expression of PD-L1 and PD-L2 on APC after exposure to IFN-γ and the expression of PD-L1 in cancer cell lines (15) and primary cancer cells (141) led to the hypothesis that blockade of the PD-1:PD-L1/2 inhibitory pathway might induce antitumor immunity. Here, CD274 is linked to cancer.